Hidden altruism in a real-world setting

被引:18
|
作者
Raihani, N. J. [1 ]
机构
[1] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England
关键词
cooperation; altruism; charity; reputation; anonymous; COMPETITIVE ALTRUISM; INDIRECT RECIPROCITY; PARTNER CHOICE; COOPERATION; EXPLANATION; ANONYMITY; BEHAVIOR;
D O I
10.1098/rsbl.2013.0884
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Concerns for reputation can promote cooperative behaviour. Individuals that behave cooperatively stand to benefit if they gain in influence, status or are more likely to be chosen as interaction partners by others. Most theoretical and empirical models of cooperation predict that image score will increase with cooperative contributions. Individuals are therefore expected to make higher contributions when observed by others and should opt to make contributions publicly rather than privately, particularly when contributions are higher than average. Here, however, I find the opposite effect. Using data from an online fundraising website, I show that donors are more likely to opt for anonymity when making extremely low and extremely high donations. Mid-range donations, on the other hand, are typically publicized. Recent work has shown that extremely generous individuals may be ostracized or punished by group members. The data presented here suggest that individuals may hide high donations to avoid these repercussions.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Efficacy of Omalizumab in a real-world setting
    Sussman, Robert
    [J]. CHEST, 2007, 132 (04) : 512S - 512S
  • [2] Experience with dulaglutide in a real-world setting
    Zouras, S.
    Stephens, J. W.
    Price, D. E.
    Syed, W.
    [J]. DIABETIC MEDICINE, 2018, 35 : 186 - 186
  • [3] Insulin thermostability in a real-world setting
    Pendsey, Sanket
    James, Steven
    Garrett, Timothy J.
    Nord, Anders Bay
    Pendsey, Sharad
    Malmodin, Daniel
    Karlsson, Goran
    Maniam, Jayanthi
    Atkinson, Mark A.
    Forsander, Gun
    Ogle, Graham D.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (05): : 310 - 312
  • [4] An Assessment of Asthma Control in a Real-World Setting
    Holguin, F.
    Hanania, N. A.
    Pennington, E. J.
    Busse, W. W.
    Chiddarwar, H.
    Zigmont, E.
    Chornak, J.
    Nelson, G.
    Ortega, H.
    Camargo, C. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Taking the data and fndings into the real-world setting
    Henry, David H.
    [J]. JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (05): : 155 - 155
  • [6] Reductions in exacerbations with omalizumab in a real-world setting
    Braunstahl, Gert-Jan
    Georgiou, Andreas
    Canvin, Janice
    Maykut, Robert
    Bruce, Jennifer
    Chen, Chien-Wei
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [7] Is lasting remission feasible in the real-world setting? No!
    Khunti, Kamlesh
    [J]. BRITISH JOURNAL OF DIABETES, 2024, 24 (01): : 97 - 98
  • [8] Teriflunomide for multiple sclerosis in real-world setting
    Elkjaer, M. L.
    Molnar, T.
    Illes, Z.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (05): : 447 - 453
  • [9] Drug survival of apremilast in a real-world setting
    Kishimoto, Megumi
    Komine, Mayumi
    Kamiya, Koji
    Sugai, Junichi
    Ohtsuki, Mamitaro
    [J]. JOURNAL OF DERMATOLOGY, 2019, 46 (07): : 615 - 617
  • [10] Efficacy of Generic Atorvastatin in a Real-World Setting
    Manasirisuk, Panisa
    Chainirun, Nanthaphan
    Tiamkao, Somsak
    Lertsinudom, Sunee
    Phunikhom, Kutcharin
    Sawunyavisuth, Bundit
    Sawanyawisuth, Kittisak
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2021, 13 : 45 - 51